In chronic HF, empagliflozin reduced a composite of CV death or HF hospitalization across kidney risk categories

Authors: Ali Ziaolhagh, Donald A. Molony

Published: 2023-09-04

DOI: 10.7326/j23-0065

Source: Full article

---

Abstract

No abstract found.